Patents by Inventor Thomas David Reed

Thomas David Reed has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ERK ligands and polynucleotides encoding ERK ligands
    Publication number: 20090186379
    Abstract: The invention relates to kinase inhibitor ligands and polyligands. In particular, the invention relates to ligands and polyligands that modulate ERK activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Application
    Filed: November 8, 2007
    Publication date: July 23, 2009
    Inventor: Thomas David Reed
  • Tubulo-vesicular structure localization signals
    Publication number: 20090181458
    Abstract: The invention relates to polarized cell tubulo-vesicular structure localization signals. The localization signals are utilized as research tools or are linked to polypeptides of interest or therapeutic molecules. Disclosed are methods of making and using polypeptides and modified polypeptides as signals to localize therapeutics, experimental compounds, peptides, proteins and/or other macromolecules to the tubulo-vesicular structures of polarized cells. The polypeptides of the invention optionally include linkage to reporters, epitopes and/or other experimental or therapeutic molecules. The invention also encompasses polynucleotides encoding the localization signals and vectors comprising these polynucleotides.
    Type: Application
    Filed: December 4, 2007
    Publication date: July 16, 2009
    Inventor: Thomas David Reed
  • mTOR LIGANDS AND POLYNUCLEOTIDES ENCODING mTOR LIGANDS
    Publication number: 20080220475
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands, homopolyligands, and heteropolyligands that modulate mTOR activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Application
    Filed: November 30, 2007
    Publication date: September 11, 2008
    Inventors: Thomas David Reed, Amy H. Atzel
  • GSK3 LIGANDS AND POLYNUCLEOTIDES ENCODING GSK3 LIGANDS
    Publication number: 20080213834
    Abstract: The invention relates to kinase ligands and polyligands. In particular, the invention relates to ligands and polyligands that modulate GSK3 activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
    Type: Application
    Filed: November 9, 2007
    Publication date: September 4, 2008
    Inventors: Thomas David Reed, Amy H. Atzel